Quantum Biopharma (TSE:QNTM) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Quantum BioPharma has successfully closed its first tranche of an offering, raising $500,000 to advance its business development and for general working capital. The company, known for its innovative solutions in treating neurodegenerative disorders, remains dedicated to its research, particularly on its lead compound Lucid-MS.
For further insights into TSE:QNTM stock, check out TipRanks’ Stock Analysis page.